The pharmaceutical company, Cetylite, announced the availability of new single-patient packaging for its topical anesthetic spray, benzocaine 14.0%, butamben 2.0%, and tetracaine hydrochloride 2.0% (Cetacaine).
NOVEMBER 8, 2017
NOVEMBER 8, 2017
The pharmaceutical company, Cetylite, announced the availability of new single-patient packaging for its topical anesthetic spray, benzocaine 14.0%, butamben 2.0%, and tetracaine hydrochloride 2.0% (Cetacaine).